TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
$ANTHROPIC·$MA····$INTC····$BLUE-ORIGIN·$SPCX····$CRWV····$CRM····$MSFT····$NVDA····$ORCL····$CURSOR·$AAPL····$OPENAI·$AMZN····$UBER····$GOOGL····$META····$TSLA····$DATABRICKS·$PERPLEXITY·$LYFT····$NBIS····$TSM····$LITE····$ANDURIL·
$ANTHROPIC·$MA····$INTC····$BLUE-ORIGIN·$SPCX····$CRWV····$CRM····$MSFT····$NVDA····$ORCL····$CURSOR·$AAPL····$OPENAI·$AMZN····$UBER····$GOOGL····$META····$TSLA····$DATABRICKS·$PERPLEXITY·$LYFT····$NBIS····$TSM····$LITE····$ANDURIL·
←

aiden

T3 · host / generalist

CEO of Nourish, a dietitian-led metabolic clinic with 10,000+ registered dietitians and virtual medical care; raised $100M Series C; focuses on combining GLP-1 medications with behavior change for sustainable outcomes.

1 call·1 name·100% bull·last heard 4 months ago·TBPN
track record

no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY

top calls

highest conviction · one per company
1sthigh conviction
$NOURISHNourishposition

Nourish raises $100M Series C for dietitian-led metabolic clinic combining GLP-1s with behavior change

Largest network of 10,000+ registered dietitians paired with virtual medical care (physicians prescribe/manage GLP-1s); thesis: medication alone yields temporary results, sustainable outcomes require integrated behavior change; AI to serve as 24/7 behavior change agent; insurance-covered model as generics drive drug costs down.

TBPN2026-05episode →

most discussed · click a bar to filter

  • $NOURISH

recurring themes

  • GLP-1 & Metabolic Drugs1
1 total
$NOURISH
Nourish
HIGHaiden·TBPN·4 months ago·Google I/O 2026, Birth Rate Debates, SpaceX IPO, Karpathy Joins Anthropic· position
Nourish raises $100M Series C for dietitian-led metabolic clinic combining GLP-1s with behavior change
Largest network of 10,000+ registered dietitians paired with virtual medical care (physicians prescribe/manage GLP-1s); thesis: medication alone yields temporary results, sustainable outcomes require integrated behavior change; AI to serve as 24/7 behavior change agent; insurance-covered model as generics drive drug costs down.
"If you don't pair that with behavior change you don't get kind of sustainable results which of course is worse for the patient but it's also worse for the system because now we've…"
65:02
8
GLP-1 & Metabolic Drugstailwind
GLP-1 commoditization shifts value to AI-powered behavior change wraparound care
Nourish CEO predicts GLP-1 costs will plummet as generics arrive (retatrutide approval coming); sustainable weight loss requires pairing medication with dietitian-led behavior change; AI serves as 24/7 behavior agent; insurance-covered integrated care model wins as drug becomes commodity.